NCT05974410 2025-10-02Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAVM Biotechnology IncAvailable
NCT01064622 2024-11-19Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic CancerNational Cancer Institute (NCI)Phase 2 Completed118 enrolled 14 charts
NCT02775227 2020-08-24HYPARHelsinki University Central HospitalPhase 4 Active not recruiting126 enrolled